Cigna Files 8-K on Executive Compensatory Arrangements

TL;DR

**Cigna just filed an 8-K about executive pay changes, watch for leadership shifts.**

AI Summary

The Cigna Group filed an 8-K on January 17, 2024, reporting an event that occurred on January 16, 2024, related to changes in its executive compensation arrangements. This filing, under Item 5.02, indicates potential shifts in how certain officers are compensated, which could impact the company's financial performance and executive retention. Investors should note that changes in compensatory arrangements can signal strategic shifts or efforts to align executive incentives with shareholder value.

Why It Matters

Changes in executive compensation can influence leadership stability and motivation, directly affecting the company's strategic direction and long-term financial health.

Risk Assessment

Risk Level: low — This filing is purely administrative, reporting a change in compensatory arrangements, and does not inherently indicate a negative or positive event without further details.

Analyst Insight

Investors should monitor subsequent filings or company announcements for specific details regarding the changes in compensatory arrangements to understand their potential impact on executive incentives and company strategy.

Key Players & Entities

• The Cigna Group (company) — registrant filing the 8-K
• January 16, 2024 (date) — date of the earliest event reported
• January 17, 2024 (date) — filing date of the 8-K
• 001-38769 (other) — Commission File Number
• 82-4991898 (other) — IRS Employer Identification No.
• Delaware (other) — State of incorporation
• 900 Cottage Grove Road Bloomfield, Connecticut 06002 (other) — Address of principal executive offices
• 860-226-6000 (other) — Registrant's telephone number
• CI (other) — Trading Symbol for Common Stock
• New York Stock Exchange (other) — Exchange where Common Stock is registered

FAQ

Key Financial Figures

• $0.01 — ch registered Common Stock, Par Value $0.01 CI New York Stock Exchange , Inc. I
• $1,000,000 — ef Executive Officer, Cigna Healthcare $1,000,000 $2,000,000 $6,000,000 Eric P. Palme
• $2,000,000 — Officer, Cigna Healthcare $1,000,000 $2,000,000 $6,000,000 Eric P. Palmer Executiv
• $6,000,000 — gna Healthcare $1,000,000 $2,000,000 $6,000,000 Eric P. Palmer Executive Vice Presi

Filing Documents

• cigna8k.htm (8-K) — 28KB
• 0000950159-24-000014.txt ( ) — 196KB
• ci-20240116.xsd (EX-101.SCH) — 3KB
• ci-20240116_lab.xml (EX-101.LAB) — 33KB
• ci-20240116_pre.xml (EX-101.PRE) — 22KB
• cigna8k_htm.xml (XML) — 3KB

02

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On January 17, 2024, The Cigna Group (the "Company") announced certain organizational changes. Among these changes, effective February 5, 2024: Brian C. Evanko will serve as President and Chief Executive Officer, Cigna Healthcare, in addition to his current role as Executive Vice President and Chief Financial Officer, The Cigna Group. Eric P. Palmer, currently President and Chief Executive Officer, Evernorth Health Services, will also assume responsibility for enterprise strategy and corporate development in the additional role of the Company's Executive Vice President for Enterprise Strategy. On January 16, 2024, the People Resources Committee of the Company's Board of Directors approved compensation changes for Mr. Evanko and Mr. Palmer to reflect the expansion of their roles and responsibilities. In connection with their respective expanded responsibilities, Mr. Evanko and Mr. Palmer received offer letters, the material terms of which are included in the table below. In addition, Mr. Evanko and Mr. Palmer will continue to be eligible to participate in the Company's employee benefit plans, in accordance with their terms. Base Salary (effective February 5, 2024) 2024 Enterprise Incentive Plan Annual Target 2024 Long-Term Incentive Annual Target Brian C. Evanko Executive Vice President and Chief Financial Officer, The Cigna Group, and President and Chief Executive Officer, Cigna Healthcare $1,000,000 $2,000,000 $6,000,000 Eric P. Palmer Executive Vice President, Enterprise Strategy, The Cigna Group, and President and Chief Executive Officer, Evernorth Health Services $1,000,000 $2,000,000 $6,000,000 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly

View Full Filing

View this 8-K filing on SEC EDGAR